Page 2 - Colorectal News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Colorectal. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Colorectal Today - Breaking & Trending Today

Married At First Sight star joins Oxford cancer trust amid chemotherapy

Married At First Sight dating coach Mel Schilling has said she is “feeling positive and confident about the future” amid cancer treatment. ....

City Of , United Kingdom , New South Wales , Neil Mortensen , Mel Schilling , Colon Cancer , Married At First Sight , Colon Cancer Trust , Sir Neil Mortensen , Cancer Diagnosis , Colorectal Surgery , Mel Schilling ,

Next-Generation Sequencing Finds More Immunotherapy-Eligible Patients

Next-generation sequencing was more successful in finding patients with endometrial and colorectal cancer with dMMR disease, indicating that they were eligible for immunotherapy. ....

United States , Elias Farhat , Amin Nassar , Yale Cancer Center , Drug Administration , Cancer Cell , Yale Cancer , Next Generation Sequencing ,

New study expands immunotherapy eligibility for colorectal and endometrial cancer patients

A new study shows thousands more patients diagnosed with colorectal and endometrial cancers could benefit from immunotherapy than are currently offered it. ....

United States , Elias Bou Farhat , Amin Nassar , Yale University , Yale Cancer Center , Repair Deficiency , Cancer Cell , Yale Cancer , Endometrial Cancer ,

Top 5 Most-Read Colorectal Cancer Articles of 2023

The topics included clinical staging of colorectal cancer, FDA approvals, and a study published in the print version of the American Journal of Managed Care®. ....

United States , Trastuzumab Deruxtecan , American Journal , Colorectal Cancer Increased , Breakthrough Therapy Designations , Solid Tumors , Advanced Refractory Colorectal , Health System Colorectal Cancer Screening ,

A Treatment Option for Metastatic Colorectal Cancer Patients with BRAFV600E Mutation in Singapore

Targeted therapy regimen, BRAFTOVI® (encorafenib) in combination with cetuximab, included on MOH Cancer Drug List, for the treatment of adult patients with BRAFV600E-mutant. ....

United States , Safaee Ardekani , Pierre Fabre Laboratorie , Jairo Pardey , National Registry Of Diseases Office , Singapore Cancer Society , International Agency For Research On Cancer , Ono Pharmaceutical Co , Health Sciences Authority , Merck Kga , Ministry Of Health , Merck Kgaa , World Health Organization , Pierre Fabre Foundation , Central Provident Fund , Health Promotion Board , Drug List , Permanent Residents , Medishield Life , Outreach Newswire , Fabre Singapore , Cancer Drug List , Pierre Fabre , Singapore Permanent Residents , General Manager , Singapore Cancer Registry Annual Report ,